Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

M.B. Overdijk; S. Verploegen; M. Bögels; M. van Egmond; J.J.L. van Bueren; T. Mutis; R.W.J. Groen; E. Breij; A.C.M. Martens; W.K. Bleeker; P.W.H.I. Parren

doi:10.1080/19420862.2015.1007813

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

M.B. Overdijk
, S. Verploegen
, M. Bögels
, M. van Egmond
, J.J.L. van Bueren
, T. Mutis
, R.W.J. Groen
, E. Breij
, A.C.M. Martens
, W.K. Bleeker
, P.W.H.I. Parren

Research output: Contribution to journal › Article › Academic › peer-review

29 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	311-320
Journal	mAbs
Volume	7
Issue number	2
DOIs	https://doi.org/10.1080/19420862.2015.1007813
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1080/19420862.2015.1007813

Antibody-mediated-phagocytosis-contributes-to-the-anti-tumor-activity-of-the-therapeutic-antibody-daratumumab-in-lymphom.pdfFinal published version, 825 KBLicence: Taverne

Cite this

Overdijk, M. B., Verploegen, S., Bögels, M., van Egmond, M., van Bueren, J. J. L., Mutis, T., Groen, R. W. J., Breij, E., Martens, A. C. M., Bleeker, W. K., & Parren, P. W. H. I. (2015). Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. mAbs, 7(2), 311-320. https://doi.org/10.1080/19420862.2015.1007813

@article{3ae7309dd4d64f5f89eff430f55d9505,

title = "Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma",

author = "M.B. Overdijk and S. Verploegen and M. B{\"o}gels and \{van Egmond\}, M. and \{van Bueren\}, J.J.L. and T. Mutis and R.W.J. Groen and E. Breij and A.C.M. Martens and W.K. Bleeker and P.W.H.I. Parren",

year = "2015",

doi = "10.1080/19420862.2015.1007813",

language = "Undefined/Unknown",

volume = "7",

pages = "311--320",

journal = "mAbs",

issn = "1942-0862",

publisher = "Landes Bioscience",

number = "2",

}

Overdijk, MB, Verploegen, S, Bögels, M, van Egmond, M, van Bueren, JJL, Mutis, T , Groen, RWJ, Breij, E, Martens, ACM, Bleeker, WK & Parren, PWHI 2015, 'Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma', mAbs, vol. 7, no. 2, pp. 311-320. https://doi.org/10.1080/19420862.2015.1007813

TY - JOUR

T1 - Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

AU - Overdijk, M.B.

AU - Verploegen, S.

AU - Bögels, M.

AU - van Egmond, M.

AU - van Bueren, J.J.L.

AU - Mutis, T.

AU - Groen, R.W.J.

AU - Breij, E.

AU - Martens, A.C.M.

AU - Bleeker, W.K.

AU - Parren, P.W.H.I.

PY - 2015

Y1 - 2015

U2 - 10.1080/19420862.2015.1007813

DO - 10.1080/19420862.2015.1007813

M3 - Article

C2 - 25760767

SN - 1942-0862

VL - 7

SP - 311

EP - 320

JO - mAbs

JF - mAbs

IS - 2

ER -